Stocks making the biggest moves in the premarket: MyoKardia, Eidos Therapeutics, DraftKings & more
Take a look at some of the biggest movers in the premarket: MyoKardia (MYOK) – The biotech company agreed to be bought by Bristol-Myers Squibb (BMY) for $225 per share in cash, or $13.1 billion – a 61% premium to its closing price on Friday. MyoKardia's lead drug is a treatment for